Top Single Use Ophthalmic Surgical Devices Companies

Global Single Use Ophthalmic Surgical Devices Market size was valued at USD 7.97 Billion in 2024 and is poised to grow from USD 8.61 Billion in 2025 to USD 15.93 Billion by 2033, growing at a CAGR of 8% during the forecast period (2026–2033). 

Global single use ophthalmic surgical devices market is moderately competitive with the presence of many well-known market players across the globe such as Alcon Inc., Bausch Health Companies, Johnson & Johnson. In which Alcon Inc., holds the highest market share owing to their wide range of offerings for the diagnosis of cataract, glaucoma, refractive errors, and others. Moreover, acquisition, product launches, mergers, and partnerships are the few major strategies opting by major key players. 'Bausch & Lomb Inc. (USA) ', 'Johnson & Johnson Vision Care Inc. (USA) ', 'Carl Zeiss Meditec AG (Germany) ', 'Topcon Corporation (Japan) ', 'Haag-Streit Holding AG (Switzerland) ', 'Essilor International S.A. (France) ', 'Hoya Corporation (Japan) ', 'Nidek Co. Ltd. (Japan) ', 'Ziemer Ophthalmic Systems AG (Switzerland) ', 'STAAR Surgical Company (USA) ', 'Beaver-Visitec International (USA) ', 'Moria SA (France) ', 'Oertli Instrumente AG (Switzerland) ', 'DTR Medical Ltd. (UK) ', 'Rumex International Co. (USA) '

Increasing prevalence of cataract and rising number of geriatric-population across the globe are the major factors driving growth of the single use ophthalmic surgical devices market, For instance, according to a report of World Health Organization (WHO), around 20 million people across the world suffer from cataract. High growth in these ocular disorders is creating significant opportunities in the ophthalmic surgeries sector.

Vision correction devices and corrective lenses for the improvement of vision for those with common refractive errors like myopia, hypermetropia, presbyopia, and astigmatism. These type of visual impairments results in low vision and blindness. The prevalence of this issues worldwide is expected to grow in the near future due to the increased screen timing, rising geriatric population, and other types of chronic problems leading to vision loss. Hence, the growing number of eye disorder cases is likely to create high demand for advanced devices, which is expected to boost the market growth throughout the forecast period.

North America dominated the global single use ophthalmic surgical devices market holding more than 35% share in 2021, and is set to continue this over the forecast period. Increasing consumer awareness, technological advancement, and presence of strong and large market players are the key factors driving the market growth in the region. For instance, in the U.S., more than 24 million people are suffering from cataract and around 7 million people have been diagnosed with diabetic retinopathy. In addition, favourable reimbursement policies from the several government bodies in the region for various surgical procedures are also expected to contribute towards the region growth.